Indonesia to override patents for live-saving medicines

The Indonesian government hopes to implement one of the largest ever examples of “compulsory licensing”, which will enable the generic manufacture of drugs still under patent. full report

Easy patents cost patients
ASIA: Patent protection clauses weaken ARV access


Activists fear less focus on HIV after 2015

BANGKOK, 28 March 2013 (PlusNews) - As a UN high-level panel completes worldwide consultations to pick development goals for 2015 and beyond, PlusNews consulted experts to see how HIV/AIDS might fit into this new agenda. full report

Third-line ARVs could widen treatment gap in Zimbabwe

HARARE, 12 March 2013 (PlusNews) - HIV/AIDS activists in Zimbabwe have welcomed the government’s move to address the problem of HIV drug resistance by introducing third-line antiretroviral drug (ARVs). But it remains unclear how the cash-strapped government will finance this, as procuring the drugs will invariably be expensive and could divert resources away from other HIV treatment efforts. full report

HIV/AIDS: Disappointment in HIV prevention trial

JOHANNESBURG, 5 March 2013 (PlusNews) - A three-year clinical trial involving over 5,000 women in East and Southern Africa has found that pre-exposure prophylaxis (PrEP) - whether a vaginal gel or an oral tablet - is not effective at preventing HIV infection in young, unmarried women. full report

Analysis: Condoms continue to confound Uganda

KAMPALA, 1 March 2013 (PlusNews) - The condom has played a central role in Uganda’s official HIV prevention strategy for over two decades, but the country has yet to get it right, with condom use declining and the government unable to meet what demand does exist. full report

[ archives ]


Other OCHA Sites
United Nations - OCHA
DFID - UK Department for International Development
Irish Aid
Swiss Agency for Development and Cooperation - SDC